CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00758576
NCT00758576N/ACompleted
CompareCT.gov

ReSTOR Natural +3.0D (Diopter) Study In Japan

Alcon Research·interventional·Posted Sep 25, 2008·Updated Dec 21, 2010

In Brief

A clinical study evaluating ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1 for Cataract. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate safety and effectiveness of ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1 when implanted to replace the natural lens following cataract removal.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 25, 2008
Enrollment StartFeb 1, 2008
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 17.8 years ago

Interventions

ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1device

Implantation with the AcrySof ReSTOR Intraocular Lens (IOL) Model SN6AD1 following cataract removal.